Prognostic Significance of Systemic Inflammatory Response in Patients with Synchronous and Metachronous Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors

Renal Cell ◽

Kinase Inhibitors ◽

Prognostic Significance ◽

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study

International Journal of Clinical Oncology ◽

10.1007/s10147-020-01797-5 ◽

2020 ◽

Vol 26 (1) ◽

pp. 154-162

Author(s):

Koichi Kido ◽

Shingo Hatakeyama ◽

Kazuyuki Numakura ◽

Toshikazu Tanaka ◽

Masaaki Oikawa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Retrospective Study ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors

10.1016/j.clgc.2016.02.005 ◽

2016 ◽

Vol 14 (5) ◽

pp. 457-464 ◽

Cited By ~ 15

Author(s):

Pawel Chrom ◽

Rafal Stec ◽

Aleksandra Semeniuk-Wojtas ◽

Lubomir Bodnar ◽

Nathaniel J. Spencer ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

First Line ◽

Fuhrman Grade ◽

Lymphocyte Ratio

The Evolution of Nephrectomy and Patient Characteristics in Metastatic Renal Cell Carcinoma Patients Enrolled Into First-Line Tyrosine Kinase Inhibitors Clinical Trials

10.1016/j.clgc.2016.03.001 ◽

2016 ◽

Vol 14 (5) ◽

pp. 415-419 ◽

Cited By ~ 1

Author(s):

Avishay Sella ◽

Kongming Wang ◽

Tal Sella

Keyword(s):

Renal Cell Carcinoma ◽

Clinical Trials ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Patient Characteristics ◽

Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?

Future Oncology ◽

10.2217/fon-2018-0503 ◽

2019 ◽

Vol 15 (9) ◽

pp. 925-927

Author(s):

Samet Yaman ◽

Burak Bilgin ◽

Mehmet AN Şendur ◽

Mutlu Hızal ◽

Muhammed Bülent Akıncı ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

Translational Andrology and Urology ◽

10.21037/tau-21-429 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Wei Xi ◽

Yingyong Hou ◽

Xiaoyi Hu ◽

Yu Xia ◽

Shuai Jiang ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Prognostic Significance

Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma

10.1016/j.clgc.2018.05.001 ◽

2018 ◽

Vol 16 (5) ◽

pp. 365-368 ◽

Cited By ~ 11

Author(s):

Andrew W. Hahn ◽

Camryn Froerer ◽

Sidney VanAlstine ◽

Nityam Rathi ◽

Erin B. Bailey ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Response To Treatment ◽

Prediction for early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors

European Urology Open Science ◽

10.1016/s2666-1683(20)33315-2 ◽

2020 ◽

Vol 19 ◽

pp. e1096

Author(s):

J. Teishima ◽

T. Hayashi ◽

S. Inoue ◽

Y. Sekino ◽

S. Fujii ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

First Line ◽

Early Progression

Indirect comparison of bevacizumab plus interferon-alpha-2a versus tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4612 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4612-4612 ◽

Cited By ~ 3

Author(s):

G. H. Mickisch ◽

B. Schwander ◽

B. J. Escudier ◽

J. Bellmunt ◽

J. P. Maroto ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Interferon Alpha ◽

Renal Cell ◽

Kinase Inhibitors ◽

Indirect Comparison ◽

Risk of treatment failure after first-line tyrosine kinase inhibitors (TKI) therapy in patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e15114 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e15114-e15114

Author(s):

G. P. Hess ◽

C. Chen ◽

Z. Liu ◽

D. H. Gesme ◽

S. S. Agarwala ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Treatment Failure ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

First Line ◽

Risk Of Treatment

Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors

10.1016/j.clgc.2019.07.014 ◽

2019 ◽

Vol 17 (6) ◽

pp. e1137-e1146

Author(s):

Seung Jea Shin ◽

Taejin Kim ◽

Hyun Hwan Sung ◽

Hwang Gyun Jeon ◽

Byong Chang Jeong ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Predictive Models ◽

Renal Cell ◽

Kinase Inhibitors ◽

Early Death ◽